[HTML][HTML] MicroRNAs in cancer and cardiovascular disease
Although cardiac tumor formation is rare, accumulating evidence suggests that the two
leading causes of deaths, cancers, and cardiovascular diseases are similar in terms of …
leading causes of deaths, cancers, and cardiovascular diseases are similar in terms of …
Molecular basis and clinical implications of HIFs in cardiovascular diseases
Y Hu, H Lu, H Li, J Ge - Trends in Molecular Medicine, 2022 - cell.com
Oxygen maintains the homeostasis of an organism in a delicate balance in different tissues
and organs. Under hypoxic conditions, hypoxia-inducible factors (HIFs) are specific and …
and organs. Under hypoxic conditions, hypoxia-inducible factors (HIFs) are specific and …
Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors
LM Khachigian, RL Varcoe, T Suoranta… - … and Vascular Biology, 2023 - Am Heart Assoc
Peripheral artery disease (PAD) is a vascular disorder caused by occlusive atherosclerosis,
which commonly impairs blood flow to the lower extremities. The prevalence of PAD is …
which commonly impairs blood flow to the lower extremities. The prevalence of PAD is …
[HTML][HTML] The role of lymphangiogenesis in cardiovascular diseases and heart transplantation
RC Ji - Heart Failure Reviews, 2022 - Springer
Cardiac lymphangiogenesis plays an important physiological role in the regulation of
interstitial fluid homeostasis, inflammatory, and immune responses. Impaired or excessive …
interstitial fluid homeostasis, inflammatory, and immune responses. Impaired or excessive …
[HTML][HTML] Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on …
AJ Leikas, S Ylä-Herttuala, JEK Hartikainen - International Journal of …, 2023 - mdpi.com
Adenoviral vectors are commonly used in clinical gene therapy. Apart from oncolytic
adenoviruses, vector replication is highly undesired as it may pose a safety risk for the …
adenoviruses, vector replication is highly undesired as it may pose a safety risk for the …
AAV-mediated gene therapy for Sialidosis
D van de Vlekkert, H Hu, JA Weesner, LE Fremuth… - Molecular Therapy, 2023 - cell.com
Sialidosis (Mucolipidosis I) is a glycoprotein storage disease, clinically characterized by a
spectrum of systemic and neurological phenotypes. The primary cause of the disease is …
spectrum of systemic and neurological phenotypes. The primary cause of the disease is …
[HTML][HTML] Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia
J Pajula, J Lähteenvuo, M Lähteenvuo… - … in Bioengineering and …, 2022 - frontiersin.org
Background: Cardiovascular diseases are the leading cause of death globally. In spite of the
availability of improved treatments, there is still a large group of chronic ischemia patients …
availability of improved treatments, there is still a large group of chronic ischemia patients …
[HTML][HTML] Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases
L Jiao, Z Sun, Z Sun, J Liu, G Deng… - … in Bioengineering and …, 2024 - frontiersin.org
Gene therapy is a technique that rectifies defective or abnormal genes by introducing
exogenous genes into target cells to cure the disease. Although gene therapy has gained …
exogenous genes into target cells to cure the disease. Although gene therapy has gained …
Manipulating bioactivities of endothelial progenitor cell-derived exosomes for promoting angiogenesis in ischemic vascular diseases
B Dong, Y Qiu, Z Liu, J Huang, Z Wang, Q Tu, Z Zhou… - Nano Today, 2023 - Elsevier
Exosomes paracrine-secreted by EPC (EPC-EXO) may exert strong pro-angiogenic effects,
which offers a potential means to treat ischemic diseases. However, the mechanism of EPC …
which offers a potential means to treat ischemic diseases. However, the mechanism of EPC …
[HTML][HTML] Recent advances in gene therapy for cardiac tissue regeneration
Cardiovascular diseases (CVDs) are responsible for enormous socio-economic impact and
the highest mortality globally. The standard of care for CVDs, which includes medications …
the highest mortality globally. The standard of care for CVDs, which includes medications …